Johnson & Johnson (JNJ) on Mon. said it had accepted a $4 bil offer from private equity firm Carlyle Group to buy its Ortho-Clinical Diagnostics business, which employs 4,500 workers. The New Brunswick, N.J.-based J&J said the sale of the blood-testing unit, which supplies equipment and chemicals to screen donated blood for HIV, hepatitis C and other serious diseases, is expected to close by midyear. J&J shares rose 0.8% to 98.23.
- Health Care Industry
- Investment & Company Information
- Carlyle Group